INFORMATION FOR
News
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
WHRY pilot project recipients have received major competitive funding support to advance their work toward clinical applications.
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
A new study has shown that clinical trials for new cancer medications rarely analyze data on safety and effectiveness by race and that black and Hispanic patients are consistently underrepresented among participants.
Women in the United States have experienced a steep rise in rates of aggressive uterine cancer since 2000, an upward trend that has been particularly steep for minority women, according to a new study.
Women's Health Research at Yale is working to eliminate the unnecessary risk too many women face during and after pregnancy.
After leading the implementation of a Picture Archiving and Communication System (PACS) to dramatically improve access to medical imaging in his home country of Tanzania, Dr. Frank Minja at Yale School of Medicine (YSM) is working alongside residents and faculty from Yale and other institutions to establish a three-year longitudinal program in Tanzania geared at training radiology residents, nurses, and technologists in interventional radiology.
Connecticut Magazine has named 77 Yale Cancer Center and Smilow Cancer Hospital at Yale New Haven physicians and surgeons to its 2018 Best Doctors guide. Published in the magazine's April issue, the Best Doctors list consists of 779 Connecticut physicians from 78 medical specialties.
A study by a Yale scientis suggests that dasatinib and similar drugs at low doses could be effective treatment for cardiovascular defects related to Noonan syndrome (NS), a genetic disorder that results in severe heart defects, and should be considered for clinical trials.
Eleven years ago, Yale scientist Gary Desir MD and his team were conducting heart disease research when they discovered a naturally occurring protein circulating at high levels in plasma. Since the protein was secreted by the kidneys and metabolized adrenaline, they named it renalase and gave it a closer look.
Yale researchers have found that the overexpression of a protein called renalase in pancreatic cancer plays a critical role in spurring the cancer’s growth while also providing a possible new target for attacking the tumors it helps develop. The findings were described in the March 14th online issue of Scientific Reports.
Yale School of Public Health researchers evaluate the association between exposure to hot temperatures during pregnancy and the risk of cancer in children.
A recent study conducted by scientists at Yale Cancer Center demonstrates that spatial gene signatures can significantly enhance the prediction of immunotherapy outcomes in patients with melanoma.
Profiles in Survivorship: Craig Studer
Dr. Vasilis Vasiliou on Yale Cancer Answers.
Learn three main areas of research within Yale Urology and what motivates the faculty behind it.
Stephen, 61, traveled over 5,000 from Hawaii to Yale to have Dr. Jennifer Moliterno perform brain surgery. Dr. Moliterno performs more brain surgeries than any other physician in Connecticut, and patients like Stephen travel long distances due to her experience and efficiency.
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
Amos S. Espinosa, a PhD Candidate in Experimental Pathology, was recently named a winner of the American Society of Hematology's Minority Hematology Graduate Award.
Melinda, 67, approached her brain tumor with the same singular focus she approaches everything in life - and with the help of a World-Class Yale surgeon.